ConductScience.org, home

Company · impulse-dynamics-87d6c024

Impulse Dynamics

4 sourcescompanies-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. Impulse Dynamics. Companies, record impulse-dynamics-87d6c024. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/impulse-dynamics-87d6c024

On this page

Company

The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.

Name
Impulse Dynamics
Trials
17
As lead sponsor
13
As collaborator
4
Recruiting
6
Active, recruiting or not
8
Completed
5
Stopped early, withdrawn or suspended
3
Posted results
4
Drugs its trials test
0
Comparisons calculated in its trials
14
First trial registered
2005-05-30
Last update
2026-11-06

Source ClinicalTrials.gov

Pipeline0

The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.

None in this release.

Trials17

The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.

TrialTitleRolePhaseStatusTypeParticipantsStartResults first postedDrugsIn TrialsSource
NCT07209098Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart FailureLead sponsorRecruitingObservational4,2002025-11-18https://conductscience.org/library/trials/NCT07209098ClinicalTrials.gov
NCT07112924CCM OPEN HF RegistryLead sponsorRecruitingObservational5,5002025-11-01https://conductscience.org/library/trials/NCT07112924ClinicalTrials.gov
NCT06973902The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HFCollaboratorRecruitingObservational1202025-07-10https://conductscience.org/library/trials/NCT06973902ClinicalTrials.gov
NCT06580392CCM and Implementation of Guideline-Directed Medical Therapy in Patients With Heart Failure (Fix-GDMT-HF)Lead sponsorRecruitingObservational2002025-02-01https://conductscience.org/library/trials/NCT06580392ClinicalTrials.gov
NCT05855135Assessment of Combined CCM and ICD Device in HFrEFLead sponsorNot applicableActive, not recruitingInterventional3002023-05-17https://conductscience.org/library/trials/NCT05855135ClinicalTrials.gov
NCT05704426Arrythmia Burden in Cardiac Contractility Modulation (CCM)CollaboratorTerminatedObservational22023-05-012024-08-19https://conductscience.org/library/trials/NCT05704426ClinicalTrials.gov
NCT05519046Cardiac Contractility Modulation in Chagas Heart DiseaseCollaboratorNot applicableRecruitingInterventional602022-05-25https://conductscience.org/library/trials/NCT05519046ClinicalTrials.gov
NCT05064709Assessment of CCM in HF With Higher Ejection FractionLead sponsorNot applicableRecruitingInterventional1,5002022-02-03https://conductscience.org/library/trials/NCT05064709ClinicalTrials.gov
NCT04755569Optimizer System With ODOCOR II CCM™ LeadsLead sponsorUnknown statusObservational2002021-03-01https://conductscience.org/library/trials/NCT04755569ClinicalTrials.gov
NCT03970343Post Approval Study (PAS) of the OPTIMIZER Smart and CCM TherapyLead sponsorActive, not recruitingObservational6202020-01-21https://conductscience.org/library/trials/NCT03970343ClinicalTrials.gov

1 to 10 of 17

See all 17 trials

Conditions30

The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.

ConditionTrials
Heart Failure10
CHF2
Chronic Heart Disease2
Congestive Heart Failure2
NYHA Class III Heart Failure2
Arrhythmias, Cardiac1
Arrythmia1
Atrial Fibrillation1
CCM Therapy1
Chagas Cardiomyopathy1

Partners5

The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.

OrganizationClassTrials sharedIn CompaniesSource
Hackensack Meridian HealthOther1ClinicalTrials.gov
I2medi Comercial Medica LTDAUnknown1ClinicalTrials.gov
InCor Heart InstituteOther1ClinicalTrials.gov
Quovadis AssociazioneOther1ClinicalTrials.gov
Stiftung Institut fuer HerzinfarktforschungOther1ClinicalTrials.gov

Data dates

The date of each source this release read.

Sponsors and results posted
2026-11-14
ClinicalTrials.gov
Trials' registrations
2026-11-12
ClinicalTrials.gov
Drug links and targets
2026-09-18
Open Targets
Comparisons
2026-03-23
Trial comparisons

Sources 4

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL
  • ClinicalTrials.govNo license stated
  • Open TargetsCC0 1.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this company from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/companies/v1/impulse-dynamics-87d6c024

GET https://conductscience.org/api/companies/v1/impulse-dynamics-87d6c024/conditions?page=2